<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>122(5)</volume><submitter>Robey BS</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>NCATS NIH HHS</funding><funding>Shire</funding><funding>Banner</funding><funding>Nutricia</funding><funding>Receptos/Celgene</funding><funding>Miraca</funding><funding>NIH</funding><funding>Meritage</funding><funding>Holoclara</funding><funding>Allakos</funding><funding>Regeneron</funding><funding>Adare</funding><funding>NIDDK NIH HHS</funding><funding>GSK</funding><journal>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</journal><pagination>532-533.e3</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6500748</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Subcutaneous immunotherapy in patients with eosinophilic esophagitis.</pubmed_title><pmcid>PMC6500748</pmcid><funding_grant_id>UL1 TR002489</funding_grant_id><funding_grant_id>T32 DK007634</funding_grant_id><pubmed_authors>Commins SP</pubmed_authors><pubmed_authors>Dellon ES</pubmed_authors><pubmed_authors>Hernandez ML</pubmed_authors><pubmed_authors>Eluri S</pubmed_authors><pubmed_authors>Jerath MR</pubmed_authors><pubmed_authors>Reed CC</pubmed_authors><pubmed_authors>Robey BS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Subcutaneous immunotherapy in patients with eosinophilic esophagitis.</name><description/><dates><release>2019-01-01T00:00:00Z</release><publication>2019 May</publication><modification>2025-04-21T16:07:42.133Z</modification><creation>2025-04-21T16:07:42.133Z</creation></dates><accession>S-EPMC6500748</accession><cross_references><pubmed>30831258</pubmed><doi>10.1016/j.anai.2019.02.022</doi></cross_references></HashMap>